Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 8,750.00
+70.00 (0.81%)
Oct 29, 2026, 3:30 PM KST
Komipharm International Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 53,018 | 52,465 | 58,779 | 42,647 | 39,801 | 35,847 |
Revenue Growth | -3.27% | -10.74% | 37.83% | 7.15% | 11.03% | -3.53% |
Gross Profit Gross Profit Growth | 18,406 | 16,911 | 21,633 | 12,527 | 11,316 | 11,107 |
Operating Income Operating Income Growth | 1,764 | 1,960 | 6,193 | -6,273 | -3,804 | -5,291 |
Net Income Net Income Growth | -2,582 | -7,209 | 13,113 | -3,979 | -6,514 | -4,459 |
Earnings Per Share EPS Growth | -35.99 | -102.00 | 188.00 | -57.00 | -93.00 | -63.64 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 26,027 | 29,632 | 38,445 | 27,254 | 24,430 | 23,670 |
Pakistan Pakistan Growth | 3,849 | 3,903 | 2,510 | - | - | - |
Bangladesh Bangladesh Growth | 6,193 | 3,856 | 3,858 | - | - | - |
Thailand Thailand Growth | 1,678 | 2,358 | 1,731 | - | - | - |
Other Asia Other Asia Growth | 4,338 | 3,958 | 3,475 | - | - | - |
Africa Africa Growth | 3,705 | 3,399 | 2,841 | - | - | - |
Middle East Middle East Growth | 6,116 | 3,843 | 3,421 | - | - | - |
South America, Europe South America, Europe Growth | 1,111 | 1,516 | 2,498 | - | - | - |
Total Total Growth | 53,018 | 52,465 | 58,779 | 42,647 | 39,801 | 35,847 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 27,313 | 27,888 | 22,448 | 14,820 | 10,805 | 13,929 |
Total Debt Total Debt Growth | 41,294 | 40,672 | 43,839 | 45,102 | 38,131 | 33,422 |
Net Cash (Debt) Net Cash Growth | -13,981 | -12,785 | -21,391 | -30,282 | -27,327 | -19,493 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -194.86 | -180.73 | -306.96 | -431.66 | -388.82 | -277.38 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 983.65 | -621.8 | 8,847 | -2,800 | -1,808 | -1,256 |
Capital Expenditures CapEx Growth | -3,404 | -3,087 | -1,045 | -636.78 | -847.71 | -813.43 |
Free Cash Flow Free Cash Flow Growth | -2,421 | -3,709 | 7,802 | -3,437 | -2,656 | -2,069 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.72% | 32.23% | 36.80% | 29.37% | 28.43% | 30.98% |
Operating Margin | 3.33% | 3.74% | 10.54% | -14.71% | -9.56% | -14.76% |
Pretax Margin | -6.27% | -15.12% | 24.99% | -13.46% | -18.79% | -16.55% |
Profit Margin | -4.87% | -13.74% | 22.31% | -9.33% | -16.37% | -12.44% |
FCF Margin | -4.57% | -7.07% | 13.27% | -8.06% | -6.67% | -5.77% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 20.39 | - | - | - |
P/FCF Ratio | - | - | 34.28 | - | - | - |
PS Ratio | 11.86 | 9.66 | 4.55 | 6.89 | 11.21 | 15.30 |